Home
Valeritas, Inc.

Valeritas, Inc. Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainvaleritas.com

Year Founded2006

Employees51 - 200

Annual Revenue$25M - $50M

Valeritas, Inc.

Valeritas, Inc. (including company regionals)

valeritas.com

See more website traffic and engagement information

Valeritas, Inc. Revenue up to June 2026 is 25M - 50M

revenue generated by Valeritas, Inc. top domains

Valeritas, Inc. top domains revenue over 3 years

Revenue for Valeritas, Inc. top domains

valeritas.com25M - 50M

See more with Sales Intelligence

Total visits to Valeritas, Inc.'s top domains

Understand Valeritas, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

valeritas.com1.2K

See more with Sales Intelligence

Avg. visit duration in Valeritas, Inc.'s top domains

Analyze Valeritas, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

valeritas.com--

See more with Sales Intelligence

Avg. pageviews on Valeritas, Inc.'s top domains

See how Valeritas, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

valeritas.com1.07

See more with Sales Intelligence

Valeritas, Inc. top competitors by domain

Top similar sites in June 2026, ranked by their affinity

catalent.comCompany NameCatalentEmployees> 10001HQUnited States, New Jersey, SomersetAnnual revenue> $1BTotal visits102.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Valeritas, Inc.

These are the website technologies, by industry, used by Valeritas, Inc. top domains

Conversion & Analytics (4)

Google Analytics

Audio Video Media (3)

YouTube

Social (3)

AddThis

Widget (3)

Google Maps

More Technologies

6

See all

News & Signals from Valeritas, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsZealand Pharma group acquired Valeritas Holdings, Inc. for $23M on Apr 1st '20.Zealand Pharma ( ZEAL.CO ) has acquired Valeritas Holdings, Inc. ( VLRX ), a U.S. based commercial-stage company for a cash purchase price of $23 million The purchase accelerates Zealand Pharma’s plans for establishing U.S. operations to support the anticipated launch of the dasiglucagon HypoPal ® rescue pen Copenhagen, April 2, 2020 – Zealand Pharma A/S (“Zealand” or the “Company”) ( ZEAL.CO ) (CVR-no.

NewsValeritas Holdings, Inc. sold assets to Zealand Pharma group in the amount of $23M on Apr 1st '20.At that time, Zealand entered into a definitive agreement to acquire substantially all assets from Valeritas.

NewsValeritas Holdings, Inc. has issues with patent infringement.Roche sued Valeritas for patent infringement in the U.S. District Court for the District of Delaware.